The race to develop oral serds and other novel estrogen receptor inhibitors: recent clinical trial results and impact on treatment options

HIGHLIGHTS

• who: Yating Wang from the Ascension Providence Hospital, Southfield, MI, USA have published the article: The race to develop oral SERDs and other novel estrogen receptor inhibitors: recent clinical trial results and impact on treatment options, in the Journal: (JOURNAL) of September/28,/2023

SUMMARY

AF, activation function; ER, estrogen receptor; ERE, estrogen response element; F, fulvestrant; RNA-poly, RNA-polymerase; T, tamoxifen ER to estrogen response elements (ERE) in the promoter of target genes (classical pathways) or a protein-protein interaction with other transcription factors at their respective promoter sites (non-classical . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.